-
公开(公告)号:US20110112071A1
公开(公告)日:2011-05-12
申请号:US13008456
申请日:2011-01-18
申请人: Hideharu UCHIDA , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
发明人: Hideharu UCHIDA , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
IPC分类号: A61K31/55 , C07D407/12 , A61K31/357 , A61P19/02 , A61P11/06 , A61P13/06 , A61P25/06 , A61P17/06 , A61P3/04 , C07D311/76 , C07D313/08 , C07D405/12 , A61K31/4725 , A61K31/4709 , C07D417/12 , A61K31/428 , C07D413/14 , A61K31/5377 , A61K31/44 , A61K31/335 , C07D401/12
CPC分类号: C07D405/12 , C07D215/14 , C07D215/38 , C07D313/08 , C07D401/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D495/04
摘要: A compound represented by formula (I′): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q′ represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
摘要翻译: 由式(I')表示的化合物:其中m,n和p各自表示0〜2; q表示0或1; R1表示卤素,烃基,杂环基,烷氧基,烷氧基羰基, 氨磺酰基,CN基,NO 2基等; R 2表示卤素,氨基,烃基,芳香族杂环基或氧代基; X 1表示O,-NR 3 - 或-S(O) R 2; X 2表示亚甲基,O,-NR 3 - 或-S(O)r - ; Q'表示杂芳基,杂芳基烷基,取代的芳基或芳烷基; 环或杂芳环;波浪线表示E-异构体或Z-异构体),化合物的盐或化合物或其盐的溶剂合物。 药物组合物和瞬时受体电位型I(TRPV1)受体拮抗剂各自含有化合物,化合物的盐和化合物或其盐的溶剂合物中的至少一种作为活性成分。
-
公开(公告)号:US07910751B2
公开(公告)日:2011-03-22
申请号:US11988659
申请日:2006-07-24
申请人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
发明人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
IPC分类号: C07D313/00 , C07D309/00
CPC分类号: C07D405/12 , C07D215/14 , C07D215/38 , C07D313/08 , C07D401/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D495/04
摘要: A compound represented by formula (I′): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q′ represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
摘要翻译: 由式(I')表示的化合物:其中m,n和p各自表示0〜2; q表示0或1; R1表示卤素,烃基,杂环基,烷氧基,烷氧基羰基, 氨磺酰基,CN基,NO 2基等; R 2表示卤素,氨基,烃基,芳香族杂环基或氧代基; X 1表示O,-NR 3 - 或-S(O) R 2; X 2表示亚甲基,O,-NR 3 - 或-S(O)r - ; Q'表示杂芳基,杂芳基烷基,取代的芳基或芳烷基; 环或杂芳环;波浪线表示E-异构体或Z-异构体),化合物的盐或化合物或其盐的溶剂合物。 药物组合物和瞬时受体电位型I(TRPV1)受体拮抗剂各自含有化合物,化合物的盐和化合物或其盐的溶剂合物中的至少一种作为活性成分。
-
公开(公告)号:US20080287428A1
公开(公告)日:2008-11-20
申请号:US11988659
申请日:2006-07-24
申请人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
发明人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
IPC分类号: A61K31/5383 , C07D405/02 , A61K31/4709 , C07D313/08 , A61K31/335 , C07D498/04
CPC分类号: C07D405/12 , C07D215/14 , C07D215/38 , C07D313/08 , C07D401/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D495/04
摘要: A compound represented by formula (I′): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q′ represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
摘要翻译: 由式(I')表示的化合物:其中m,n和p各自表示0〜2; q表示0或1; R 1表示卤素,烃基,杂环基, 烷氧基,烷氧基羰基,氨磺酰基,CN基,NO 2 2基等; R 2表示卤素,氨基,烃基, 芳族杂环基或氧代基; X 1表示O,-NR 3 - 或-S(O)r - ; X 2, SUB>表示亚甲基,O,-NR 3 - 或-S(O)r - ; Q'表示杂芳基,杂芳基烷基,取代的芳基或芳烷基 ;环状部分表示芳基环或杂芳基环;波浪线表示E-异构体或Z-异构体),化合物的盐或化合物或其盐的溶剂合物。 药物组合物和瞬时受体电位型I(TRPV1)受体拮抗剂各自含有化合物,化合物的盐和化合物或其盐的溶剂合物中的至少一种作为活性成分。
-
公开(公告)号:US08383839B2
公开(公告)日:2013-02-26
申请号:US13008456
申请日:2011-01-18
申请人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
发明人: Hideharu Uchida , Naoto Kosuga , Tsutomu Satoh , Daido Hotta , Tomoyuki Kamino , Yoshitaka Maeda , Ken-ichi Amano , Yasushige Akada
IPC分类号: C07D313/00 , C07D309/00
CPC分类号: C07D405/12 , C07D215/14 , C07D215/38 , C07D313/08 , C07D401/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D495/04
摘要: A compound represented by formula (I′): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, —NR3—, or —S(O)r-; X2 represents a methylene group, O, —NR3—, or —S(O)r-; Q′ represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
摘要翻译: 由式(I')表示的化合物:其中m,n和p各自表示0〜2; q表示0或1; R1表示卤素,烃基,杂环基,烷氧基,烷氧基羰基, 氨磺酰基,CN基,NO 2基等; R 2表示卤素,氨基,烃基,芳香族杂环基或氧代基; X 1表示O,-NR 3 - 或-S(O) R 2; X 2表示亚甲基,O,-NR 3 - 或-S(O)r - ; Q'表示杂芳基,杂芳基烷基,取代的芳基或芳烷基; 环或杂芳环;波浪线表示E-异构体或Z-异构体),化合物的盐或化合物或其盐的溶剂合物。 药物组合物和瞬时受体电位型I(TRPV1)受体拮抗剂各自含有化合物,化合物的盐和化合物或其盐的溶剂合物中的至少一种作为活性成分。
-
-
-